Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €460.76 EUR
Change Today +2.97 / 0.65%
Volume 21.0
RGO On Other Exchanges
Symbol
Exchange
Munich
As of 9:38 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Pension Plan for regeneron pharmaceuticals (RGO)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2014 in U.S. Dollars
Projected Benefit Obligation--
Accumulative Benefit Obligation--
Total Pension Assets--
Def. Benefit Service Cost--
Def. Benefit Plan Interest Cost--
Def. Benefit Plan Return On Assets--
Def. Benefit Plan Other Cost--
Def. Benefit Plan Total Cost--
Def. Contribution Plan Cost13.10
Total Pension Expense13.10
Exp. Ret. on Pension Assets--
Discount Rate on Obligation--
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.--
Other Benefits Obligation--

Stock Options for regeneron pharmaceuticals (RGO)

Outstanding at Beginning of Year21.41
Issued During the Year3.91
Exercised During the Year3.56
Canceled During the Year0.25
Outstanding at the End of Year21.51
W/Avg. Exercise Price of Options Granted385.33
W/Avg. Exercise Price of Options Outstanding158.54
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGO:GR €460.76 EUR +2.97

RGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $137.98 USD +1.14
Incyte Corp $107.19 USD +1.61
Kyowa Hakko Kirin Co Ltd ¥1,638 JPY -26.00
UCB SA €65.61 EUR +0.03
Vertex Pharmaceuticals Inc $129.10 USD -2.16
View Industry Companies
 

Industry Analysis

RGO

Industry Average

Valuation RGO Industry Range
Price/Earnings 100.0x
Price/Sales 17.1x
Price/Book 17.6x
Price/Cash Flow 148.4x
TEV/Sales 16.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.